BASI Financial Facts

Operating income (loss): -365K
Total operating expenses: 1.54M
See Full Income Statement

Total current liabilities: 13.81M
Current portion of long-term debt: 3.86M
See Full Balance Sheet

Bioanalytical Systems (BASI) Earnings

  |   Expand Research on BASI
Next EPS Date 2/14/17 *Est. EPS Growth Rate +100.0% *Last Qtr.
Average EPS % Beat Rate -125.0% Revenue Growth Rate -100.0% *Last Qtr.
Average % Move 1-Wk after EPS +8.9% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
12/22/16 Q416 N/AN/A N/A N/AN/A N/A N/A N/A
8/11/16 Q316 -$0.05N/A N/A $5.05M$6.15M N/A Details
5/12/16 Q216 -$0.03N/A N/A $5.34M$5.73M N/A Details
2/16/16 Q116 -$0.06N/A N/A $4.9M$5.95M N/A Details
12/17/15 Q415 -$0.09N/A N/A $4.98M$6.42M N/A Details
8/13/15 Q315 $0.16N/A N/A $6.15M$6.03M N/A Details
5/14/15 Q215 -$0.01N/A N/A $5.73M$5.92M N/A Details
2/12/15 Q115 $0.01N/A N/A $5.85M$6.22M N/A Details